EN DE

PT Medco Energi Internasional Tbk, (MDCOY) Fair Value & Analysis

Energy · US · Market cap $1.7B

PM PT Medco Energi Internasional Tbk, logo PT Medco Energi Internasional Tbk, MDCOY · US
Price$7.00
Fair Value$11.20
Upside+60.0%
Quality45/100
Watch PT Medco Energi Internasional Tbk, for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 6.2% net margin
High debt · generates free cash flow
Ranks above peers (12/13)
Narrow moat 42/100
Evidence: Medium Range $9.00 – $15.02 Share as image

Fair value as of: Jul 17, 2026

From 20 valuation models · updated 24 days ago

Fair value updated Jul 17, 2026, revised from $6.48 to $11.20 (+72.8%) since Jun 24, 2026.

Below-average quality, screening 60% undervalued on our models.

What matters now

  • The price is below even our cautious bear case ($9.00). The market is more pessimistic than our downside scenario.
  • Solid quality (45/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (8 months)

$7.00 $6.47 Fair Value $11.20 Dec 2025 Aug 2026

White line = price, green steps = our fair value per fiscal year. As of Jul 17, 2026.

How to read this chart

8‑month range $6.47 – $7.00 · fair‑value band $9.00 – $15.02 · the $7.00 price screens below the $11.20 fair value. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

PT Medco Energi Internasional Tbk, (MDCOY) currently trades at $7.00, while our model-based Fair Value estimate is $11.20, implying the stock looks roughly 60.0% undervalued today. The Quality Score stands at 45/100 (below-average quality), in the Energy sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, PT Medco Energi Internasional Tbk, generated revenue of $2.4B at a net margin of 6.2%. Revenue grew 19.2% year over year. It earns a return on equity of 7.0%. Net debt stands at $3.1B. Fundamentals as of Jul 17, 2026

Our scenario range runs from $9.00 (bear case) to $15.02 (bull case); at $7.00, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 5% above its 52-week low, currently above its 200-day average. For context, the median of 10 Energy peers we cover trades at -26% fair-value upside, at 60%, MDCOY screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $3.68 $9.04 $15.63 80
Residual Income $6.23 $6.11 $5.30 76
Rev-Margin DCF $4.11 $9.47 74
All 20 models by family
DCF Models
FCF DCF $3.55 $9.64 $17.59 38
5Y Revenue Exit $3.91 $9.40 39
5Y P/E Exit $2.11 38
10Y Revenue Exit $0.7900 $5.01 $10.27 36
10Y P/E Exit $2.31 $5.25 35
Earnings-Based
Graham-Dodd $2.78 $8.04 $10.61 54
Lynch FV $1.66 $2.37 $3.08 50
PEG = 1.0 $1.66 $2.37 $3.08 46
EPV $6.70 $9.13 $11.15 59
Multiples
P/E Multiple $4.29 $5.72 $7.16 63
P/S Multiple $5.21 $6.95 $8.69 58
P/B Multiple $5.21 $6.95 $8.69 55
EV/EBIT $10.02 $17.06 $24.09 53
EV/Revenue $0.5700 $4.06 43
Asset-Based
NCAV (Graham) $4.36 $5.85 $8.73 50
Growth DCF
Growth DCF $3.68 $9.04 $15.63 80
Rev-Margin DCF $4.11 $9.47 74
Economic Profit
Residual Income $6.23 $6.11 $5.30 76
ROIC Compounder $6.70 $9.30 $12.82 72
Growth Earnings
Growth-Adj P/E $3.63 $5.18 $6.74 68

Widest divergence: Multiples ($6.95) versus Earnings-Based ($2.37). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $2.4B
Revenue growth (YoY) +19.2%
Net margin 6.2%
Return on equity 7.0%
Free cash flow $391M FY2025
P/E ratio 11.5
More key figures
Operating margin 25.0%
EPS (TTM) $0.6100
EPS growth (YoY) +288%
Net debt $3.1B FY2025

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 45/100

Of which business quality 44 · Market factors (momentum, volatility) 63

Profitability 23
Margins and returns on capital today
Quality Growth 31
Are margins and returns improving?
Cashflow 71
Earnings quality: real cash, not paper profit
Fin. Strength 16
Balance sheet, leverage, solvency risk
Investment 44
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 54
Price trend over the last 3–12 months (market factor)
52W Momentum 35
Distance to the 52-week high (market factor)
Net Issuance 92
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

PT Medco Energi Internasional Tbk, together with its subsidiaries, explores for and produces oil and gas in Indonesia, Asia, Africa, the Middle East, and the United Kingdom. It operates through Exploration and Production of Oil and Gas; Services; Power; Chemicals; and Trading segments.

Full company description

PT Medco Energi Internasional Tbk, together with its subsidiaries, explores for and produces oil and gas in Indonesia, Asia, Africa, the Middle East, and the United Kingdom. It operates through Exploration and Production of Oil and Gas; Services; Power; Chemicals; and Trading segments. The company operates an independent power producer in the gas, geothermal, and other renewables sectors, as well as manages a portfolio of onshore and offshore assets in the Middle East, Africa, and the Asia Pacific. It is also involved in copper and gold mining operations in Sumbawa and Nusa Tenggara; and providing operation and maintenance services, and support services for oil and gas activities. The company was formerly known as PT Medco Energi Corporation and changed its name to PT Medco Energi Internasional Tbk in 2000. The company was founded in 1980 and is headquartered in Jakarta, Indonesia. PT Medco Energi Internasional Tbk operates as a subsidiary of Pt Medco Daya Abadi Lestari.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

PT Medco Energi Internasional Tbk, reported revenue of $2.4B in FY2025 versus $1.3B in FY2021, a compound +17.6%/yr. Reported net income was $101M in FY2025, compounding +21.0%/yr from FY2021.

Growth Quality 36/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$2.4B
Latest YoY
−0.2%
Avg. growth/yr (3Y)
+1.2%
Revenue +17.6%/yr
FY21 $1.3B
FY22 $2.3B
FY23 $2.2B
FY24 $2.4B
FY25 $2.4B
Net income +21.0%/yr
FY21 $47.0M
FY22 $531M
FY23 $331M
FY24 $367M
FY25 $101M

Watch MDCOY: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "PT Medco Energi Internasional Tbk, Fair Value". https://www.fairvalue-calculator.com/stock/MDCOY

Peer Group

Oil & Gas E&P · 315 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 45 · Above median
Fair Value upside +60% · Top 25%
Return on equity (TTM) 7% · Above median
Return on assets 5% · Top 25%
Net margin (TTM) 6% · Above median
Operating margin (TTM) 25% · Above median
Revenue growth 19% · Above median
Debt / equity 1.53× · Higher than 75% of peers

Valuation Multiples vs Oil & Gas E&P median · lower = cheaper

P/E (TTM) 11.5× · Cheaper than median
P/B 0.80× · Cheaper than median
P/S (TTM) 0.71× · Cheaper than 75% of peers
P/FCF 4.4× · Cheaper than median
EV/EBITDA 4.1× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 14
FUTURE 96 · sector 0
PAST 28 · sector 0
HEALTH 23 · sector 87
DIVIDEND 0 · sector 66

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Oil & gas

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Oil & Gas E&P stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
CNOOC Limited 600938 ¥28.97 ¥32.55 +12%
ConocoPhillips explores for, COP $109.04 $91.79 -16%
Canadian Natural Resources Limited CNQ $42.86 $31.54 -26%
EOG Resources, Inc EOG $139.89 $130.19 -7%
Occidental Petroleum Corporation OXY $54.86 $30.68 -44%
Diamondback Energy, Inc FANG $183.39 $106.12 -42%
Devon Energy Corporation DVN $43.83 $27.06 -38%
Woodside Energy Group WDS A$30.46 A$20.71 -32%
EQT Corporation EQT $48.85 $42.85 -12%
Texas Pacific Land Corporation TPL $415.70 $79.20 -81%

Compare PT Medco Energi Internasional Tbk, with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Energy stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is PT Medco Energi Internasional Tbk, (MDCOY) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of $11.20 versus a price of $7.00, about +60% (undervalued).
What is the fair value of MDCOY?
Our model-based fair value for PT Medco Energi Internasional Tbk, is $11.20 (as of Jul 17, 2026), built from audited fundamentals. The current price is $7.00.
What is the quality score of MDCOY?
PT Medco Energi Internasional Tbk, has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of PT Medco Energi Internasional Tbk, (MDCOY)?
PT Medco Energi Internasional Tbk, reported trailing-twelve-month revenue of about $2.4B (latest available figure, as of Jul 17, 2026).
What is the net profit margin of MDCOY?
The net profit margin of PT Medco Energi Internasional Tbk, is about 6.2%, meaning it keeps roughly 6.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track PT Medco Energi Internasional Tbk, and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.